Raloxifene and breast cancer risk

被引：0
|
作者：
Banks E.
机构：
来源：
Breast Cancer Research | / 1卷 / 1期
关键词：
Breast cancer; Endometrial cancer; Raloxifene; Selective estrogen receptor modulator; Venous thromboembolism;
D O I：
10.1186/bcr-1999-66588
中图分类号：
学科分类号：
摘要：
[No abstract available]
引用
收藏
相关论文
共 50 条
  • [31] Chemoprevention of breast cancer with tamoxifen and raloxifene
    Weiss, JM
    Diedrich, K
    Ortmann, O
    [J]. GYNAKOLOGE, 2003, 36 (02): : 97 - 102
  • [32] Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
    Vogel, Victor G.
    [J]. BREAST CANCER-TARGETS AND THERAPY, 2011, 3 : 127 - 137
  • [33] Effect of raloxifene on invasive breast cancer incidence by baseline breast cancer risk in postmenopausal women at risk for major coronary events.
    Geiger, M. J.
    Song, J.
    Dowsett, S. A.
    Barrett-Connor, E.
    Cauley, J.
    Grady, D.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2006, 100 : S169 - S169
  • [34] Effects of raloxifene on the incidence of invasive breast cancer in postmenopausal women at low and high risk of breast cancer by the gail model
    Goldstein, Steven R.
    Mershon, John
    Wong, Mayme
    Natanegara, Fanni
    Mitchell, Beth D.
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2006, 13 (06): : 1001 - 1001
  • [35] Effect of raloxifene on bone mineral density in premenopausal women at increased risk of breast cancer
    Eng-Wong, J.
    Reynolds, J. C.
    Venzon, D.
    Liewehr, D.
    Gantz, S.
    Danforth, D.
    Liu, E. T.
    Chow, C.
    Zujewski, J.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (10): : 3941 - 3946
  • [36] Use of raloxifene and tamoxifen by breast cancer risk level in a Medicare-eligible cohort
    Pinsky, Paul F.
    Miller, Eric
    Heckman-Stoddard, Brandy
    Minasian, Lori
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2018, 218 (06) : 606.e1 - 606.e9
  • [37] Randomized clinical trials of raloxifene: reducing the risk of osteoporosis and breast cancer in postmenopausal women
    Olevsky, Olga M.
    Martino, Silvana
    [J]. MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (04): : 790 - 796
  • [38] Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk
    Grady, Deborah
    Cauley, Jane A.
    Geiger, Mary Jane
    Kornitzer, Marcel
    Mosca, Lori
    Collins, Peter
    Wenger, Nanette K.
    Song, Jingli
    Mershon, John
    Barrett-Connor, Elizabeth
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (12) : 854 - 861
  • [39] COST EFFECTIVENESS ANALYSIS OF BREAST CANCER RISK REDUCTION THERAPY: COMPARING TAMOXIFEN AND RALOXIFENE
    Poon, J. L.
    Hay, J.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A37 - A37
  • [40] The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancer
    Wickerham, D. Lawrence
    Costantino, Joseph P.
    Vogel, Victor G.
    Cronin, Walter M.
    Cecchini, Reena S.
    Ford, Leslie G.
    Wolmark, Norman
    [J]. CANCER PREVENTION II, 2009, 181 : 113 - 119
12345